NASDAQ:PTPI
Petros Pharmaceuticals Inc Stock Company Profile
$0.617
-0.0214 (-3.35%)
At Close: May 13, 2024
Information
1185 Avenue of the Americas, Suite 249
New York NY 10036
973-242-0005
www.petrospharma.com
Industry: Drug Manufacturers—Specialty & Generic
Sector: Healthcare
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
